Who owns ACTINIUM PHARMACEUTICALS INC?
- Ticker: ATNM
- CUSIP Number: 00507w206
Tip: Access positions for across all investors
Analyze quarterly positions in Actinium Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Actinium Pharmaceuticals stock
Who bought or sold ACTINIUM PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BlackRock | 1.7M | $13M | -3% | Mar 2024 |
|
Vanguard Group | 1.4M | $11M | 6% | Mar 2024 |
|
Geode Capital Management | 596k | $4.7M | 10% | Mar 2024 |
|
Verition Fund Management | 506k | $4.0M | 100% | Mar 2024 |
|
Susquehanna International | 246k | $1.9M | 33% | Mar 2024 |
|
Northern Trust | 231k | $1.8M | 5% | Mar 2024 |
|
Citadel Advisors | 167k | $1.3M | 93% | Mar 2024 |
|
Marshall Wace | 153k | $1.2M | 100% | Mar 2024 |
|
Brandywine Global Investment Management | 146k | $1.1M | 0% | Mar 2024 |
|
Dimensional Fund Advisors | 145k | $1.1M | -2% | Mar 2024 |
|
ADAR1 Capital Management | 100k | $783k | 100% | Mar 2024 |
|
Nuveen Asset Management | 99k | $778k | 0% | Mar 2024 |
|
Hudson Bay Capital Management | 93k | $730k | 100% | Mar 2024 |
|
Bridgeway Capital Management | 84k | $658k | 31% | Mar 2024 |
|
Charles Schwab Investment Management | 76k | $597k | 0% | Mar 2024 |
|
Morgan Stanley | 71k | $553k | 46% | Mar 2024 |
|
Millennium Management | 67k | $528k | 100% | Mar 2024 |
|
Bank of New York Mellon | 67k | $528k | -41% | Mar 2024 |
|
Royce & Associates | 50k | $392k | 0% | Mar 2024 |
|
Jane Street | 50k | $391k | 68% | Mar 2024 |
|
Bank of America Corporation | 39k | $306k | -21% | Mar 2024 |
|
Rhumbline Advisers | 32k | $252k | 2% | Mar 2024 |
|
UBS Group | 28k | $217k | -7% | Mar 2024 |
|
Lighthouse Investment Partners | 26k | $207k | 100% | Mar 2024 |
|
Creative Financial Designs | 23k | $179k | 15% | Mar 2024 |
|
Group One Trading | 23k | $177k | 100% | Mar 2024 |
|
Virtu Financial | 20k | $99k | 100% | Dec 2023 |
|
Barclays | 19k | $152k | -49% | Mar 2024 |
|
American Century Companies | 19k | $148k | 100% | Mar 2024 |
|
Intrepid Financial Planning Group | 16k | $125k | -11% | Mar 2024 |
|
National Asset Management | 15k | $86k | 0% | Mar 2024 |
|
MetLife Investment Advisors | 14k | $70k | 0% | Dec 2023 |
|
Wells Fargo & Company | 14k | $107k | 10% | Mar 2024 |
|
American International | 14k | $69k | 2% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 14k | $106k | -4% | Mar 2024 |
|
New York State Common Retirement Fund | 13k | $99k | 0% | Mar 2024 |
|
Am Investment Strategies | 13k | $99k | 100% | Mar 2024 |
|
Perritt Capital Management | 12k | $94k | 0% | Mar 2024 |
|
Jpmorgan Chase & Co | 12k | $92k | -37% | Mar 2024 |
|
Goldman Sachs Group | 11k | $87k | -28% | Mar 2024 |
|
Ing Investment Management | 10k | $80k | -8% | Mar 2024 |
|
Advisor Group Holdings | 10k | $80k | 53% | Mar 2024 |
|
Sanders Morris Harris | 10k | $78k | 100% | Mar 2024 |
|
Simplex Trading | 9.1k | $71k | -47% | Mar 2024 |
|
Royal Bank of Canada | 5.5k | $0 | -59% | Mar 2024 |
|
Citigroup | 4.7k | $36k | 18% | Mar 2024 |
|
Qube Research & Technologies | 3.2k | $25k | 100% | Mar 2024 |
|
Legal & General Group | 3.0k | $24k | 0% | Mar 2024 |
|
FMR | 2.9k | $23k | -8% | Mar 2024 |
|
California State Teachers Retirement System | 2.8k | $22k | -53% | Mar 2024 |
|
Tower Research Capital | 2.3k | $18k | -1% | Mar 2024 |
|
Summit Investment Advisors | 2.1k | $17k | 0% | Mar 2024 |
|
Metropolitan Life Insurance Company | 1.4k | $7.3k | 0% | Dec 2023 |
|
Retirement Group | 1.2k | $9.3k | 0% | Mar 2024 |
|
Amalgamated Bank | 877.00 | $7.0k | -76% | Mar 2024 |
|
National Bank Of Canada /fi/ | 855.00 | $4.5k | 0% | Dec 2023 |
|
BFSG | 500.00 | $3.9k | 0% | Mar 2024 |
|
Hartford Financial Management | 266.00 | $2.1k | 0% | Mar 2024 |
|
Northwestern Mutual Wealth Management Company | 107.00 | $838.002600 | 0% | Mar 2024 |
|
Pnc Financial Services | 100.00 | $783.000000 | 100% | Mar 2024 |
|
Steward Partners Investment Advisory | 100.00 | $783.000000 | 0% | Mar 2024 |
|
CWM | 91.00 | $999.999000 | -49% | Mar 2024 |
|
Coppell Advisory Solutions | 7.00 | $36.000300 | 100% | Dec 2023 |
|
Nelson, Van Denburg & Campbell Wealth Management | 5.00 | $39.000000 | 100% | Mar 2024 |
|
Who sold out of Actinium Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Mirae Asset Global Investments | Dec 2023 | 14k | $73k |
Advisory Services Network | Dec 2023 | 2.1k | $11k |
Hazlett, Burt & Watson | Dec 2023 | 200.00 | $1.0k |
Gradient Investments | Dec 2023 | 66.00 | $335.002800 |